The Phase 2 trial enrolled participants with obesity and evaluated multiple dose levels over 48 weeks: 1 mg dose: 8.7% average body weight reduction 4 mg dose (escalated from 2 mg): 17.1% average body weight reduction 8 mg dose (escalated from 2 mg): 22.8% average body weight reduction 12 mg dose (escalated from 2 mg): 24.2% average body weight reduction Placebo: 2.1% average body weight reduction Those Phase 2 numbers were striking enough
A4.YES, generally our MOQ is 100pcs for trial order
However, incorporating a control tube that contains the same biological sample but lacks glutathione substrate can help to identify and prevent the interfering effect of thiols, ensuring more reliable and accurate test results
Dehydration reaches an emergency level if you experience severe confusion, an inability to remain awake, fainting spells, chest pain, or if you completely stop producing urine for more than 12 hours
We assume competitive drugs with this triple mechanism are in the pipeline
After 68 weeks on semaglutide, patients had lost an average of over 15% of their body weight
